secwatch.observer — SEC 8-K summary
======================================

Issuer:     Moderna, Inc. (MRNA)
CIK:        0001682852
Form:       8-K
Filed at:   2022-05-03T23:59:59+00:00
Accession:  0001682852-22-000016
Event type: other_material
Sentiment:  neutral
Materiality: 0.15
Item codes: 5.07
LLM model:  deepseek-v4-flash:cloud@v2

Moderna shareholders elect directors, approve executive compensation, ratify auditor at 2022 annual meeting
--------------------------------------------------------------------------------

- Directors elected: Noubar Afeyan (231.4M for), Stéphane Bancel (246.8M for), François Nader (234.2M for); broker non-votes 34.7M.
- Advisory vote on named executive officer compensation passed with 277.97M for (93% of votes cast).
- Ratification of Ernst & Young as auditor for FY2022 passed with 251.9M for (76% of votes cast).
- Shareholder proposal requesting report on IP transfer feasibility failed with 70.9M for (24% of votes cast).

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1682852/000168285222000016/0001682852-22-000016-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1682852/000168285222000016/mrna-20220428.htm
  HTML page:      https://secwatch.observer/filing/0001682852-22-000016

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer